1,395
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway

, , , , , & show all
Pages 507-513 | Received 02 Jan 2019, Accepted 28 May 2019, Published online: 10 Aug 2019

References

  • Ambrosini G, Adida C, Altieri DC. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 3:917–921.
  • Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. 2017. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 71:96–108.
  • Barth AI, Nathke IS, Nelson WJ. 1997. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol. 9:683–690.
  • Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. 1999. beta-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 155:1033–1038.
  • Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. 2001. Gender- and smoking-related bladder cancer risk. J Nat Cancer Inst. 93:538–545.
  • Cindolo L, Palmieri EA, Autorino R, Salzano L, Altieri V. 2004. Standard versus hydrophilic catheterization in the adjuvant treatment of patients with superficial bladder cancer. Urol Int. 73:19–22.
  • Cui R, He J, Wang B, Zhang F, Chen G, Yin S, Shen H. 2003. Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol. 51:75–80.
  • Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H, Yang S. 2014. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res: Ptr. 28:1275–1283.
  • Fukuda S, Pelus LM. 2006. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther. 5:1087–1098.
  • Haas K, Staller P, Geisen C, Bartek J, Eilers M, Moroy T. 1997. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene. 15:179–192.
  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science. 281:1509–1512.
  • Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR. 1983. Superficial bladder cancer: progression and recurrence. J Urol. 130:1083–1086.
  • Herr HW. 1992. Intravesical BCG: current results, natural history and implications for urothelial cancer prevention. J Cell Biochem. 16I:112–119.
  • Li LY, Wang C, Wang J, Xi X, Pan SX, Ma FF, Lv W, Liao Y. 2016. Protective effects of active part of Sagittaria sagittifolia L. on hepatocytes injury in vitro. Glob Tradit Chin Med. 9:905–908.
  • Li X, Qu L, Dong Y, Han L, Liu E, Fang S, Zhang Y, Wang T. 2014. A review of recent research progress on the Astragalus genus. Molecules. 19:18850–18880.
  • Lipponen PK. 1995. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer. J Pathol. 175:203–210.
  • Ma XQ, Shi Q, Duan JA, Dong TT, Tsim KW. 2002. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agri Food Chem. 50:4861–4866.
  • McBride D. 2015. American Cancer Society recommends fewer mammograms. ONS Connect. 30:14.
  • McCrea PD, Turck CW, Gumbiner B. 1991. A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science. 254:1359–1361.
  • Miller JR, Moon RT. 1996. Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Develop. 10:2527–2539.
  • Peifer M. 1997. beta-Catenin as oncogene: the smoking gun. Science. 275:1752–1753.
  • Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature. 414:105–111.
  • Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM. 2004. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun. 320:1103–1111.
  • Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, et al. 2001. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 19:666–675.
  • Wang J, Luo W, Li B, Lv J, Ke X, Ge D, Dong R, Wang C, Han Y, Zhang C, et al. 2018. Sagittaria sagittifolia polysaccharide protects against isoniazid- and rifampicin-induced hepatic injury via activation of nuclear factor E2-related factor 2 signaling in mice. J Ethnopharmacol. 227:237–245.
  • Yu C, Cao H, Chen L, He X, Feng Y, Zhao Y, Zeng R, Gong H. 2018. Clinical stusy of effects of Qici Sanling decoction on postoperative recurrence rate of patients with non-muscle invasive bladder cancer. Shanghai J Tradit Chin Med. 52:1007–1334.
  • Zee-Cheng RK. 1992. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Meth Find Exper Clin Pharmacol. 14:725–736.
  • Zhang Z, Cheng L, Li J, Farah E, Atallah NM, Pascuzzi PE, Gupta S, Liu X. 2018. Inhibition of the Wnt/β-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer. Cancer Res. 78:3147–3162.
  • Zhao LH, Ma ZX, Zhu J, Yu XH, Weng DP. 2011. Characterization of polysaccharide from Astragalus radix as the macrophage stimulator. Cell Immunol. 271:329–334.
  • Zhao P, Fu J, Yao B, Jia Y, Zhang H, Li X, Dong L, Gao Y, Liu W, Chen W, et al. 2016. Label-free quantitative proteomic analysis of benzo(a)pyrene-transformed 16HBE cells serum-free culture supernatant and xenografted nude mice sera. Chemico-Biol Inter. 245:39–49.